Web所有smarcb1突变的病例也有smarca2突变，而smarca2和smarca4突变相互排斥，smarcb1和smarca4之间也是如此 。 2.2 核心亚基 SMARCB1几乎在所有恶性横纹肌样肿瘤（malignant rhabdoid tumor, MRT）中都存在基因缺失或截短突变，是MRT中唯一的重复性遗传异常 [ 13 ] 。 WebJun 30, 2024 · Although SMARCB1/INI1-deficient tumors are predominantly sarcomas, this is a diverse group of tumors with mixed phenotypes, which can often make the diagnosis challenging. Prognosis for these aggressive tumors is often poor. Moreover, refractory and relapsing progressive disease is common. As a result, accurate and timely diagnosis is …
Gene of the month: SMARCB1 Journal of Clinical Pathology
WebYou can see various sequences for this gene: cDNA (ENST00000344921.11) Protein (SMARCB1) Transcript and protein aligned (ENST00000344921.11+SMARCB1) Gene fusions. No fusions involving SMARCB1. Drug sensitivity data. Mutations in SMARCB1 are associated with altered sensitivity to the following drug: Axitinib. WebProtein (SMARCB1) Transcript and protein aligned (ENST00000344921.11+SMARCB1) Gene fusions No fusions involving SMARCB1 Drug sensitivity data Mutations in … black and blue quotes
SMARCB1 Gene - Somatic Mutations in Cancer - Wellcome Sanger …
The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be … See more SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 is a protein that in humans is encoded by the SMARCB1 gene. See more SMARCB1 has been shown to interact with: • ARID1A, • BAZ1B, • BRCA1, • CREB-binding protein, See more • FactorBook Ini1 See more • Miller MD, Bushman FD (1995). "HIV integration. Ini1 for integration?". Curr. Biol. 5 (4): 368–70. doi:10.1016/S0960-9822(95)00074-1. PMID 7627549. S2CID 17647431. • Van Maele B, Debyser Z (2005). "HIV-1 integration: an interplay between HIV-1 … See more WebOct 1, 2016 · SUMMARY: SMARCB1 (INI1)-deficient sinonasal carcinomas were first described in 2014, and this series of 17 cases represents the first imaging description. This tumor is part of a larger group of SMARCB1 -deficient neoplasms, characterized by aggressive behavior and a rhabdoid cytopathologic appearance, that affect multiple … WebHong D. Xiao, Carlo B. Bifulco, in Oral, Head and Neck Oncology and Reconstructive Surgery, 2024 INI-1 Deficient Sinonasal Carcinoma. INI-1 (SMARCB1) deficiency has been implicated in a variety of carcinomas and sarcomas and was recently found to be also present in some sinonasal carcinomas.By IHC, loss of INI-1 expression is identified in 6% of sinonasal … black and blue rams sideline hat